CHICAGO, June 10, 2024 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration…
Often called a wonder drug for type 2 diabetes and obesity, semaglutide — the active…
NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction Part of…
CHICAGO, June 7, 2024 — The Alzheimer’s Association announced a two-year partnership with Alpha Phi…
The World Health Organization (WHO) has issued a warning about counterfeit batches of the semaglutide…
Delta-8-THC use reported by 11% of 12th graders in 2023 Use of the psychoactive cannabis…
— June is Alzheimer’s & Brain Awareness Month — CHICAGO, June 3, 2024 — This…
Burgers made from plants or animals: Which is better for you? A new analysis of…
NIH scientists find weak points on Epstein-Barr virus New details of EBV protein could aid…
WASHINGTON, D.C., May 23, 2024 — Today the Senate Committee on Health, Education, Labor and…
